This mutation, occurring at the residue 21 of Aβ, the position contiguous to the major BACE2 cleavage sites, suppresses the efficiency of the cleavages and results in a substantial increase in the levels of iAβ and the early onset of AD [161]. Here, BACE2 is linked to Alzheimer disease.